JP2022507697A5 - - Google Patents
Info
- Publication number
- JP2022507697A5 JP2022507697A5 JP2021527114A JP2021527114A JP2022507697A5 JP 2022507697 A5 JP2022507697 A5 JP 2022507697A5 JP 2021527114 A JP2021527114 A JP 2021527114A JP 2021527114 A JP2021527114 A JP 2021527114A JP 2022507697 A5 JP2022507697 A5 JP 2022507697A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024230959A JP2025066719A (ja) | 2018-11-19 | 2024-12-26 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862769327P | 2018-11-19 | 2018-11-19 | |
| US62/769,327 | 2018-11-19 | ||
| US201962861781P | 2019-06-14 | 2019-06-14 | |
| US62/861,781 | 2019-06-14 | ||
| PCT/US2019/062238 WO2020106736A1 (en) | 2018-11-19 | 2019-11-19 | Compounds and compositions for treating conditions associated with sting activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024230959A Division JP2025066719A (ja) | 2018-11-19 | 2024-12-26 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507697A JP2022507697A (ja) | 2022-01-18 |
| JP2022507697A5 true JP2022507697A5 (https=) | 2022-11-29 |
| JPWO2020106736A5 JPWO2020106736A5 (https=) | 2022-11-29 |
Family
ID=69005817
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527114A Pending JP2022507697A (ja) | 2018-11-19 | 2019-11-19 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
| JP2024230959A Pending JP2025066719A (ja) | 2018-11-19 | 2024-12-26 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024230959A Pending JP2025066719A (ja) | 2018-11-19 | 2024-12-26 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230047905A1 (https=) |
| EP (1) | EP3883651A1 (https=) |
| JP (2) | JP2022507697A (https=) |
| CN (2) | CN113382772B (https=) |
| MA (1) | MA55138A (https=) |
| WO (1) | WO2020106736A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112823036B (zh) | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| MA54753A (fr) * | 2019-01-17 | 2021-11-24 | Ifm Due Inc | Composés et compositions pour traiter des états pathologiques associés à une activité de sting |
| US20220227760A1 (en) * | 2019-05-29 | 2022-07-21 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN114761804A (zh) | 2019-06-21 | 2022-07-15 | 艾福姆德尤股份有限公司 | 治疗癌症的方法 |
| WO2021206158A1 (ja) | 2020-04-10 | 2021-10-14 | 小野薬品工業株式会社 | がん治療方法 |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| WO2022140397A1 (en) | 2020-12-22 | 2022-06-30 | Ifm Due, Inc. | Methods of treating cancer |
| US20240060982A1 (en) | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| TW202235073A (zh) | 2021-01-08 | 2022-09-16 | 美商Ｉｆｍ Ｄｕｅ有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| GB202110084D0 (en) * | 2021-07-13 | 2021-08-25 | Univ Oxford Innovation Ltd | Sulfur compounds and processes and intermediates useful in the preparation thereof |
| WO2023285788A1 (en) * | 2021-07-13 | 2023-01-19 | Oxford University Innovation Limited | Sulfur compounds and processes and intermediates useful in the preparation thereof |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US7754755B2 (en) * | 2004-09-23 | 2010-07-13 | Bristol-Myers Squibb Company | Inhibitors of 15-lipoxygenase |
| US20100160324A1 (en) * | 2004-12-30 | 2010-06-24 | Astex Therapeutics Limited | Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases |
| WO2012075380A1 (en) | 2010-12-03 | 2012-06-07 | The Trustees Of The University Of Pennsylvania | Tip60 inhibitors |
| US9549944B2 (en) * | 2013-05-18 | 2017-01-24 | Aduro Biotech, Inc. | Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling |
| CN109394752A (zh) | 2013-10-21 | 2019-03-01 | 德雷克塞尔大学 | 治疗慢性乙型肝炎病毒感染的sting激动剂的用途 |
| CA3042317A1 (en) * | 2016-11-01 | 2018-05-11 | F.Hoffmann-La Roche Ag | Pyridazine derivatives as rorc modulators |
| US11021511B2 (en) * | 2017-01-27 | 2021-06-01 | Janssen Biotech, Inc. | Cyclic dinucleotides as sting agonists |
| WO2019076778A1 (en) * | 2017-10-16 | 2019-04-25 | Syngenta Participations Ag | HETEROCYCLIC DERIVATIVES HAVING PESTICIDAL ACTIVITY HAVING SUBSTITUENTS CONTAINING SULFUR AND SULFONIMIDAMIDES |
| US20210236466A1 (en) * | 2018-07-03 | 2021-08-05 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
-
2019
- 2019-11-19 EP EP19827876.4A patent/EP3883651A1/en not_active Withdrawn
- 2019-11-19 CN CN201980089438.2A patent/CN113382772B/zh active Active
- 2019-11-19 WO PCT/US2019/062238 patent/WO2020106736A1/en not_active Ceased
- 2019-11-19 CN CN202411912017.4A patent/CN119735540A/zh active Pending
- 2019-11-19 US US17/294,965 patent/US20230047905A1/en not_active Abandoned
- 2019-11-19 MA MA055138A patent/MA55138A/fr unknown
- 2019-11-19 JP JP2021527114A patent/JP2022507697A/ja active Pending
-
2024
- 2024-12-26 JP JP2024230959A patent/JP2025066719A/ja active Pending